William E. Rote
Chief Research Officer · 4 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | William E. Rote | Chief Research Officer | May 6, 2026 | Sale | $43.95 | 2,763 | $121.4K | 115,474 | |
TVTX | William E. Rote | Chief Research Officer | May 4, 2026 | Option Exercise | $0.00 | 4,250 | — | 118,237 | |
TVTX | ROTE WILLIAM E. | — | May 6, 2026 | Proposed Sale | $43.95 | 2,763 | $121.4K | — | |
TVTX | William E. Rote | Chief Research Officer | Apr 22, 2026 | Sale | $39.09 | 9,100 | $355.7K | 113,987 | |
TVTX | ROTE WILLIAM E. | — | Apr 22, 2026 | Proposed Sale | $39.09 | 9,100 | $355.7K | — | |
TVTX | William E. Rote | Chief Research Officer | Feb 3, 2026 | Sale | $32.87 | 12,446 | $409.1K | 109,087 | |
TVTX | ROTE WILLIAM E. | — | Feb 3, 2026 | Proposed Sale | $32.87 | 12,446 | $409.1K | — | |
TVTX | ROTE WILLIAM E. | — | Dec 24, 2025 | Proposed Sale | $40.10 | 60,000 | $2.4M | — | |
TVTX | ROTE WILLIAM E. | — | May 5, 2025 | Proposed Sale | $21.05 | 3,198 | $67.3K | — | |
TVTX | ROTE WILLIAM E. | — | Feb 12, 2025 | Proposed Sale | $23.53 | 5,200 | $122.4K | — | |
TVTX | ROTE WILLIAM E. | — | Feb 3, 2025 | Proposed Sale | $19.78 | 8,951 | $177.1K | — | |
TVTX | ROTE WILLIAM E. | — | Jan 22, 2025 | Proposed Sale | $19.46 | 2,437 | $47.4K | — | |
TVTX | ROTE WILLIAM E. | — | Sep 9, 2024 | Proposed Sale | $11.52 | 4,387 | $50.5K | — |